InflaRx (NASDAQ:IFRX) Price Target Raised to $10.00 at Guggenheim
InflaRx (NASDAQ:IFRX – Free Report) had its target price hoisted by Guggenheim from $7.00 to $10.00 in a report published on Wednesday morning, Ratings reports. The brokerage currently has a buy ...
shelbynews.com4d
Concealed carry reciprocity advances from House Judiciary
Allowing people with state-issued concealed carry licenses or permits to conceal a handgun in any other state, a bill ...
InflaRx’s (IFRX) “Buy” Rating Reaffirmed at HC Wainwright
HC Wainwright reissued their buy rating on shares of InflaRx (NASDAQ:IFRX – Free Report) in a report issued on Friday morning ...
InflaRx Reports Full Year 2024 Results and Highlights Key Achievements and Expected Milestones
Received European Commission approval for GOHIBIC® (vilobelimab) for the treatment of SARS-CoV-2-induced acute respiratory distress syndrome ...
The Joplin Globe18d
pSemi, a Murata Company, Takes Power Conversion to the Next Level at APEC 2025
Semi, a global electronics innovator and Murata company, today announced a breakthrough in multi-level buck regulator technology that promises to revolutionize the mobile battery charging industry.